Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells
Author:
Funder
East Carolina University
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology
Reference227 articles.
1. Imatinib is still recommended for frontline therapy for CML;Hantel;Blood Adv,2018
2. A second-generation TKI should always be used as initial therapy for CML;Cortes;Blood Adv,2018
3. mTOR signaling confers resistance to targeted cancer drugs;Guri;Trends Cancer,2016
4. Emerging role of mTOR in the response to cancer therapeutics;Ilagan;Trends Cancer,2016
5. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway;Manning;Mol. Cell,2002
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation;Translational Oncology;2024-10
2. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30
3. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance;Cells;2024-01-26
4. mTOR signaling and Alzheimer's disease: What we know and where we are?;CNS Neuroscience & Therapeutics;2023-09-18
5. Signaling pathways and regulation of gene expression in hematopoietic cells;Advances in Biological Regulation;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3